Dr. Jan B. Vermorken provides his perspective on the recent and emerging advances in induction and maintenance therapy in head and neck cancer. He also discusses current studies related to the treatment of patients who are HPV-positive and HPV-negative and the future advances in those areas.
Interview with Jan B. Vermorken, MD, PhD | Belgium
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Publication Dates
Release Date:
Overview
Dr. Jan B. Vermorken provides his perspective on the recent and emerging advances in induction and maintenance therapy in head and neck cancer. He also discusses current studies related to the treatment of patients who are HPV-positive and HPV-negative and the future advances in those areas.
Publication Dates
Release Date:
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Pulmonary Hypertension Management: Practice Trends and Updates
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?